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Abstract
Recent studies have suggested a bacterial role in the development of autoimmune disorders including type 1 diabetes
(T1D). Over 30 billion nucleotide bases of Illumina shotgun metagenomic data were analyzed from stool samples collected
from four pairs of matched T1D case-control subjects collected at the time of the development of T1D associated
autoimmunity (i.e., autoantibodies). From these, approximately one million open reading frames were predicted and
compared to the SEED protein database. Of the 3,849 functions identified in these samples, 144 and 797 were statistically
more prevalent in cases and controls, respectively. Genes involved in carbohydrate metabolism, adhesions, motility, phages,
prophages, sulfur metabolism, and stress responses were more abundant in cases while genes with roles in DNA and
protein metabolism, aerobic respiration, and amino acid synthesis were more common in controls. These data suggest that
increased adhesion and flagella synthesis in autoimmune subjects may be involved in triggering a T1D associated
autoimmune response. Extensive differences in metabolic potential indicate that autoimmune subjects have a functionally
aberrant microbiome. Mining 16S rRNA data from these datasets showed a higher proportion of butyrate-producing and
mucin-degrading bacteria in controls compared to cases, while those bacteria that produce short chain fatty acids other
than butyrate were higher in cases. Thus, a key rate-limiting step in butyrate synthesis is more abundant in controls. These
data suggest that a consortium of lactate- and butyrate-producing bacteria in a healthy gut induce a sufficient amount of
mucin synthesis to maintain gut integrity. In contrast, non-butyrate-producing lactate-utilizing bacteria prevent optimal
mucin synthesis, as identified in autoimmune subjects.
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Introduction
As the incidence of type 1 diabetes (T1D) in developed countries
has been increasing at a rate far beyond the rate of population
growth, environmental factors have been considered as likely
candidates responsible for this change in disease incidence in
recent decades [1–3]. Of those factors, the gut microbiota have
come under recent interest; supported in part by observations in
both non-obese diabetic (NOD) mice and BioBreeding Diabetes
Prone (BB-DP) rats where antibiotic use prevents the onset of
diabetes [4,5]. Initial studies found that NOD mice raised in germ-
free environments would spontaneously develop diabetes [6],
while a recent study suggested that rather than being diminished
under germ-free conditions, the development of T1D can be
prevented through modulation of the intestinal microbiota [7].
Likewise, both the NOD mouse and BB-DP rats treated with
Freund’s adjuvants or Lactobacillus strains delayed or decreased
incidence of diabetes [8–16]. With respect to mechanisms of
action, the gut microbiome of NOD mice lacking an adaptor for
multiple innate immune receptors responsible for recognizing
microbial stimuli correlates with disease onset, revealing a
relationship between gut microbiota and the immune system [15].
To explore specific differences in the microbial communities
responsible for T1D modulation, 16S rRNA amplicons were
sequenced from BB-DP and BioBreeding Diabetes Resistant (BB-
DR) rat stool samples collected around the time of diabetes onset
[17]. This analysis revealed bacteria genera whose members were
either positively or negatively correlated with diabetes. Lactobacillus
and Bifidobacterium were more abundant in BB-DR rats while
Bacteroides and Clostridium were more abundant in BB-DP rats. Both
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Lactobacillus and Bifidobacterium are well known to have members
with probiotic characteristics.
In humans, inflammatory bowel diseases (IBD) such as Crohn’s
and ulcerative colitis, are thought to be autoimmune and have
been correlated with a depletion of commensal bacteria from the
phyla Firmicutes and Bacteroidetes [18]. Fecal microbial commu-
nities in identical twins with Crohn’s disease show a decrease in
diversity when compared to healthy twins; likewise, the microbial
communities of the twins with Crohn’s disease were less similar to
one another than the communities from the healthy individuals
[19]. Evidence from IBD studies indicates that gut microbiota are
responsible for driving inflammatory responses regulated by
regulatory T cells. Without regulatory T cells, commensal gut
microbiota can erroneously stimulate an inflammatory response
and cause IDB [20]. Autoimmune diseases such as multiple
sclerosis, rheumatoid arthritis, psoriasis, and T1D have all been
related to an increase in Th1/Th17 as the result of an elevated or
uncontrolled immune response [21].
With respect to human T1D, the proportion of bacteria within
the phylum Bacteroidetes increases over time in unhealthy (i.e.,
autoantibody positive, ‘‘autoimmune’’) subjects while in healthy
non-T1D prone subjects, the proportion of the Firmicutes within
the population increases [22]. In addition, the case samples within
that study were less diverse than the control samples, and case
microbiomes had lower Shannon diversity compared to those in
individuals who progressed towards autoimmune T1D [22]. Over
time, case microbial communities became increasing less similar to
each other compared to the control communities who were more
similar to each other. Taxonomic identity provides information
regarding the microbial communities, but falls short of expressing
the functions present in the environment. To determine the
functions that define the autoimmune microbiome, metagenomics
analysis was needed and forms the subject of this report.
Methods
Ethics statement
This research has been approved in writing by the Institutional
Review Board of the University of Florida. The analysis of the
stool samples was done without knowledge of the identity of the
human subjects. The Diabetes Prevention and Prediction study
group in Finland obtained informed consent from the parents of
the subjects involved for the collection of the stool samples.
Written consent was obtained from the parents to collect these
samples.
The samples used in this study came from eight Finnish children
described previously [22]. Fecal samples were taken after two
autoimmune antibodies were identified in the four case samples,
and at corresponding time points in controls. The children were
age matched and were all HLA-DQ genotype positive. DNA
extraction was performed as described previously [23] and
sequencing was conducted by Argonne National Laboratory.
The original sequences are submitted to GenBank as study
accession number SRA036573.1.
The metagenome library produced paired reads with an overlap
region of approximately 30 bases. Paired sequences were
assembled using a custom script, stitch.py. Sequences that were
not paired were quality trimmed using default CLC Genomics
Workbench version 4.0 (CLC) parameters. Reads less than 50
bases in length were discarded.
The average genome size of each sample was calculated using a
recently described normalization method [24] whereby the
metagenome data is mined for the highly conserved, single copy
genes rplA, rplD, rpoB, rpsJ, rplC, rpoA, rpsG, and rpsQ. Genome size
calculations are made on the basis of the abundance of these genes
found within each metagenomic sample.
Comparisons of functions determined directly from contigs
using BLASTX revealed highly similar microbiomes at the
function level. However, because this analysis was only conducted
at the contig level, information was only provided about the
presence or absence of a particular function. Because of this
restriction, little could be done to compare between samples. It is
speculated that this is primarily as a result of the depth of
sequencing in which even low abundant genomes are sequenced
and their DNA fragments are assembled into contigs. Since the gut
microbiomes in the study are comprised of highly similar
functions, it was determined that a qualitative approach was
needed in order to resolve differences between the metagenomes.
Rather than making direct comparisons of contigs to sequenced
genomes, in which the prevalence of particular functions cannot
be determined, a quantitative approach was taken in which each
contig was used as the basis for ORF prediction using the Prodigal
algorithm, followed by an assessment of the coverage of each
ORF.
Prodigal was run using a metagenome setting in which pre-
created training files are used to make the predictions. The output
of the algorithm includes both the nucleotide sequences and their
amino acid translations. The nucleotide sequences were used to
determine the coverage of each ORF by mapping reads back to
them using the same parameters that were used during de novo
assembly. The number of reads mapped to an ORF correlates to
the prevalence of the function within the genomes of the
microbiome. The amino acid sequences were used for functional
annotation using phmmer.
Phmmer conducts alignments of amino acid sequences to amino
acid databases much like BLASTP does. However, unlike
BLASTP, phmmer uses a hidden Markov model to predict
protein domains, thus affording the algorithm greater specificity
and a lower rate of false positives. The SEED database was chosen
for the ORF alignments because of its subsystem structure. With
the goal being to group functions found within the microbiomes
into hierarchical structures, in order to determine if a particular
subsystem or subsystem hierarchy (in addition to function) is more
prevalent in cases or controls, the SEED database was filtered for
references with subsystem information.
Having established the abundance of each function and
functional hierarchy based on the number of reads, it is possible
to make a quantitative comparison between the abundance of
functions within the microbiomes. However, due to the large
number of sequences representing each microbiome, and the
relatively small counts within each function, statistical methods
such as chi-square are unable to determine significance. To
overcome this, a Poisson model was used.
De novo assemblies were conducted using a global CLC
alignment with parameters dependent on read length. The most
stringent cost values for mismatches, insertions, and deletions were
used. A minimum contig length of 400 bases was required. Open
reading frames were predicted from contigs produced from the de
novo assemblies using the metagenome implementation of
Prodigal v.2.0 (citation). To determine the coverage of each
ORF, CLC reference assemblies were conducted to the nucleotide
sequences of each ORF using the parameters used during de novo
assembly.
Functions were assigned to predicted ORFs by protein
alignments with phmmer v.3.0 (http://hmmer.org/) and a version
of the SEED database downloaded in August 2010 and modified
to included only sequences with subsystem annotations. Only
alignments with E-values less than 1026 were considered for
Metagenomics of Autoimmunity for Type 1 Diabetes
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functional assignment. The best phmmer hit for each ORF was
selected by choosing the match with the highest full-sequence bit-
score. The full-sequence bit-score is calculated by summing the
bit-scores for each protein domain, and the individual domain bit-
scores are calculated based on a hypothetical envelope of where
the domain is located on the protein, based on the hidden Markov
model of the phmmer algorithm.
To compare the metabolic potential of case and control
metagenomes, each functional hierarchy and function defined by
the SEED subsystems database was quantified by the number of
reads in each sample for that function.
The ORFs that did not have significant matches to the SEED
subsystem database were combined and their amino acid
sequences were clustered using CD-HIT v.4.3 and a 40%
sequence identity threshold. The corresponding nucleotide
translations for the sequences from each cluster were used to
determine the coverage of each cluster, in each sample, using CLC
and the reference assembly parameters that were used for
functional ORF coverage analysis.
Taxonomic assignment was conducted on all reads over 50
bases long. Classification was determined through reference
assemblies to an RDP database containing sequences for Archaea,
Bacteria, and Eukaryota, modified by TaxCollector [25]. RDP
and viral genome databases were downloaded in February 2011,
and a fungal ITS database in September 2010. The assemblies
were conducted using CLC at 98% length fraction with similarity
cutoffs that varied based on the taxonomic level being analyzed
(Figure 1).
The number of reads in each functional hierarchy, function,
cluster, and OTU were used in a Poisson log-linear regression
model to identify categories with significantly different read counts
between cases and controls. A p-value of 0.01 or less was chosen as
the criterion for statistical significance.
KEGG maps were drawn based on statistically significant
functions annotated by SEED subsystem database entries with
enzyme commission (EC) numbers. Principal component analysis
(PCA) was conducted on abundance measures for SEED functions
and OTUs. For both SEED functions and OTUs, the raw counts
were standardized by dividing by the total number of reads for each
sample, and the subsequent fractions were log transformed. After
log transforming the SEED function abundances, the data were
centered using the formula found in the supplemental materials.
OTUs were first filtered by significance according to the Poisson
model (OTUs were required to have a p-value of 0.01) before PCA
was performed. The calculations for PCA were done using the R
‘‘prcomp’’ function and plotted using the ‘‘plot’’ function.
The statistical model was fit as a generalized linear mixed model
with log link. A subject specific random effect was used to control
Figure 1. The pipeline of metagenome sequence analysis used in this work.
doi:10.1371/journal.pone.0025792.g001
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for the correlation, this is typically called a Poisson regression
model with a subject specific random effect. To fit the data, the
glmer package in R, under the library lme4, with family =Poisson,
was used [26–28].
Results
Average genome size
To determine whether our analyses might be skewed by a
difference in average genome size between cases and controls, the
average genome size within the DNA of each sample was
determined. No difference in average genome size between the
case and control samples was observed using a paired, two-tailed t-
test (Fig. S1). The average genome size of the control metagenomes
was 2.8760.21 Mbp while that of the case metagenomes was
2.4860.18 Mbp. Thus, any quantitative functional differences
observed between cases and controls cannot be attributed to any
bias related to differences in average genome size.
Steps in metagenome analysis
The analysis of the metagenomes in this work had four
objectives: 1) the calculation of the diversity of predicted proteins
in each sample; 2) the quantitative differences in the abundance of
functions between cases and controls; 3) the depiction of these
differences on KEGG maps, and 4) the mining of highly conserved
rRNA genes to determine the taxonomic differences between cases
and controls (Fig. 1). A guiding principle of this work was to
determine the quantitative differences in the functions of cases and
controls by mapping the raw reads back to the predicted ORFs by
reference assembly. Those ORFs were identified through the
assembly of the data.
The de novo assemblies made from these data resulted in contigs
representing 89% of total reads after pairing and quality trimming.
A minimum contig length of 400 bases was required for the entry
of any contig into our database. The largest contig was
444,885 bp. The average contig length was 1,487 bases, and the
median length was 634 bases. Prodigal was used to predict an
average of 121,523 ORFs per sample, which represented 77% of
all paired and unpaired reads. Phmmer alignments to the SEED
subsystem database established functional assignment for an
average of 118,928 ORFs per sample representing 42% of all
reads. All ORFs were classified to 2,887 functions and 959
functional hierarchies.
Analysis of the metagenomics data
According to the Poisson model, 911 functions exhibit a
statistically significant difference in prevalence between cases and
controls, where 114 were more prevalent in cases and 797 in
controls (supporting dataset S1). At the most general functional
hierarchy, carbohydrates and stress responses were more prevalent
in cases, while 17 hierarchies, mostly in secondary metabolism,
were more prevalent in controls (Fig. 2, supporting dataset S1).
The Poisson model identifies nearly eight times as many functions
with a greater abundance in controls verses cases. These functions
are also of much greater abundance than those identified in cases
(supporting dataset S1).
Abundances for all functions were used for principle compo-
nents analysis (PCA) in order to determine the clustering of
samples (Fig. S2). PCA reveals that the controls all exhibit similar
functionality while the cases all express different functions between
each other and the controls. The majority of SEED functions are
annotated with EC numbers. These EC numbers can be used to
Figure 2. Statistically significant metabolic steps in controls (blue) and cases (red).
doi:10.1371/journal.pone.0025792.g002
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map functions identified with SEED onto KEGG maps (Fig. S3).
Of the 1,061 pathways identified in KEGG, 24 and 166 were
statistically more prevalent in cases and controls, respectively
(Fig. 2). The complete list of functions and subsystems, their
abundances, the results of the Poisson model, and their prevalence
in either cases or controls, can be found within the supplemental
data (supporting dataset S2). Among all of the metagenome
samples, CD-HIT clustered 517,636 predicted ORFs with
unknown function into 186,005 clusters. Of these, 38,645 have
more than 100 reads, and according to the Poisson model, 3,791
exhibit a statistically significant difference in the number of reads
between cases and controls.
The metagenomic data was also mined for 16S rRNA. Using
reference assembly, all reads were mapped against the TaxCol-
lector-modified RDP database for 16S rRNA [25]. Assuming that
there is one 16S rRNA gene (1,400 bases long) for every megabase
of DNA sequenced in a metagenome, 19.49 gigabases in the eight
metagenomes would contain 19,490 16S rRNA genes and 219,670
16S rRNA reads. Taxonomic assignment based on the 16S rRNA
gene assigned 251,058 reads to the domain bacteria and 126,817
reads to known bacterial species. The complete list of operational
taxonomic units at six taxonomic levels, their relative abundances,
the statistical results, and their prevalence in either cases or
controls is available in the supplementary material (supporting
dataset S3).
At the phylum level and at p-values less than 0.001,
Actinobacteria, Bacteroidetes, and Proteobacteria were higher in
cases while Firmicutes, Fusobacteria, Tenericutes, and Verruco-
microbia were higher in controls. With a p-value of 0.01 or less,
161 genera of bacteria were found that differed in abundance
between cases and controls (supporting dataset S4). Of these, 79
were higher in cases, with the remaining 82 higher in controls.
The differences between cases and controls are particularly
striking at the genus level. The greatest % differences between
cases and controls were in the genera Prevotella and Bacteroides
where Prevotella was much more abundant in controls and
Bacteroides was much higher in cases (Fig. 3, supporting dataset
S4). The large decline in Bacteroides in controls compared to cases is
compensated entirely by Prevotella and the butyrate producers.
The butyrate producers include members of the genera Eubacte-
rium, Fusobacterium, Anaerostipes, Roseburia, Subdoligranulum, Faecalibac-
terium, and other cultured genera, which have not yet been given
genus names (supporting dataset S4).
In contrast to the butyrate producers, the lactate producers,
Lactoabcillus, Lactococcus, Bifidobacterium, and Streptococcus were more
abundant in cases; with the difference between cases and controls
being 1.19% of all 16S rRNA reads. Another group of interest is
the mucin-degrading bacteria in the genera Prevotella and
Akkermansia. There is a 20- and 140-fold higher proportion of
Prevotella and Akkermansia, respectively, in controls compared to
cases. Prevotella is the second most abundant genus in controls
comprising over 8.8% of all 16S rRNA reads. All of these trends
observed at the genus level are also seen at the species level. Other
bacteria that compete with the butyrate producers for lactate as
carbon source, such as Veillonella, produce propionate from lactate
fermentation rather than butyrate. Veillonella can compete for
lactate substrate with the butyrate producers and are in statistically
higher abundance in cases than controls. Cases possessed 6.7 times
more Veillonella than did controls. Other genera known to produce
short chain fatty acids (SCFA) other than butyrate, such as
Bacteoides, and Alistipes were proportionately higher in cases than
controls. In summary, the 16S rRNA data shows that the
increased proportion of bacteria in cases that produce SCFA
other than butyrate producers are substituted by a corresponding
increase in the proportion of butyrate producers and mucin
degraders, in control subjects (Fig. 4).
The functional data support the 16S rRNA results which
suggest a higher level of butyrate production in control micro-
biomes. The proportion of reads that assemble to butyryl-CoA
dehydrogenase (EC 1.3.99.2) is significantly higher in controls (p
value = 0.0005) than in cases. Butyryl-CoA dehydrogenase cata-
lyzes an important rate-limiting step in butyrate synthesis in E. coli
[29]. Unfortunately, the known mucin degradation genes [30] are
not present in the SEED database used for the discovery of gene
functions in these datasets. In addition, the mucin degrading genes
have only been described in one organism, making it difficult to
mine these genes accurately from metagenomic data.
Discussion
Our previous work showed taxonomic differences between the
gut microbiomes of healthy children compared to autoimmune
children in a cohort of samples from Finland [22]. In this work, the
Figure 3. Mean proportion of the 11 most abundant genera
that differ significantly between cases and controls (p val-
ue#0.01).
doi:10.1371/journal.pone.0025792.g003
Figure 4. Mean proportion of four functional groups that differ
significantly between cases and controls (p value#0.01).
Depicted is the abundance of 16S rRNA reads that are assigned to
genera known to produce butyrate, lactate, or other short chain fatty
acids (SCFA) such as propionate, acetate, or succinate. Also shown is the
proportion of bacteria that degrade mucin.
doi:10.1371/journal.pone.0025792.g004
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objective was to learn the metabolic potential of these bacterial
communities by shotgun sequencing DNA extracted from the stool
collected from children at approximately the time when they were
diagnosed as autoimmune. A new approach to the analysis of
metagenomic DNA is described herein which allows the statistical
quantitative analysis of the functional differences between cases
and controls.
The analysis methodology described herein revealed striking
functional differences between cases and controls. These were seen
at the levels of community processes, whole pathways as well as for
individual genes. At the community level, the microbiome of the
healthy children are far more functionally diverse than are the
autoimmune microbiomes. For example, for nearly every major
function category, as defined by the SEEDS subsystems, the
relative abundance of reads was statistically higher in controls
rather than cases. These major categories include amino acid
metabolism, carbohydrate metabolism, RNA metabolism, DNA
metabolism, cell wall and capsule proteins, nucleotides and
nucleosides, cofactors and vitamins, motility and chemotaxis,
nitrogen metabolism, membrane transport, phosphorous metab-
olism, virulence, and respiration.
The lower functional diversity in cases suggests that the case
microbiomes possess more bacteria that are fastidious, requiring
more nutrients in the external environment for survival and
growth. If the gut epithelial layer in autoimmune children is leaky
as suggested by Vaarala et al. [3], the host may be leaking more
Figure 5. Forty known functions that differ significantly between cases and controls (p value#0.01) as determined by the log of the
ration between cases and controls. Twenty of these functions are the highest in cases relative to controls while the other twenty are the highest
in controls relative to cases.
doi:10.1371/journal.pone.0025792.g005
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substrates into the gut than is typically seen in healthy large
intestines. In contrast, the abundance of reads that map to ORFs
of unknown function is statistically higher in cases than controls.
So although, the vast majority of bacteria found in both control
and case samples can be identified to the genus level, the case
genomes are much less well characterized at the functional level.
One reason for this is that there appears to be a much higher
abundance of anaerobes in cases than controls. One indicator of
higher anaerobicity in cases is the higher number of reads
mapping to sulfur metabolism in cases. Control communities have
far more genes involved in aerobic respiration while cases have far
more anaerobic respiratory reductases. As anaerobic bacteria are
more difficult to characterize genetically than are aerobic bacteria,
it is not surprising that less is known about their biochemistry than
the aerobes.
Although more reads controls are found that match known
virulence determinants than in cases, there are significantly more
reads in cases for some very specific virulence factors such as
adhesions, Staphylococcus pathogenicity island genes, and antibiotic
resistances. The forty most abundant differences between cases
and controls show that stress responses, virulence factors, phages,
prophages, quorum sensing, and motility genes are much more
abundant in terms of the % of total reads in cases than controls
(Fig. 5). In contrast, controls are more abundant in functions
related to central metabolism such as DNA, RNA, and protein
metabolism and respiration.
One of the intriguing findings with these data relates to a
possible role of butyrate production in the maintenance of gut
health. Butyrate is known as an anti-inflammatory short chain
fatty acid that contributes to colon health [31–33]. The 16S rRNA
mining of these data shows that many of the bacterial genera
significantly more abundant in controls compared to cases are
butyrate producers. In addition, butyrate induces mucin synthesis
[34,35], decreases bacterial transport across metabolically stressed
epithelia [36], and improves the intestinal barrier by increasing
tight junction assembly [37,38]. Mucin is a glycoprotein made by
the host that is believed to maintain the integrity of the gut
epithelium. Perspective signatures of increased mucin synthesis in
the gut may be the presence of Prevotella and Akkermansia as both
genera are known to degrade mucin [30,39]. Akkermansia and
Prevotella are significantly more abundant in the controls than in
the cases. Thus, a working hypothesis for a role for bacteria in
preventing autoimmunity is that the presence of butyrate
producing bacteria in healthy individuals may be inducing mucin
synthesis in the gut, which maintains gut integrity. The presence of
Akkermansia and Prevotella in the gut may provide a useful, simple
prediction of mucin content in the gut.
All of these data, as well as work from others in the literature,
suggest a model for the role of bacteria in a healthy gut (Fig. 6).
The total number of lactic acid producing and butyrate producing
bacteria is higher in controls than in cases [22]. Butyrate induces
mucin synthesis [34,35,40,41]. The higher number of butyrate
producers in controls is confirmed by 16S rRNA analysis and by a
higher abundance in controls of a key enzyme that catalyzes a
rate-limiting step in butyrate synthesis. Mucin is well known as a
glycoprotein produced by the host that contributes to gut integrity
[42]. Prevotella and Akkermansia are much more abundant in
controls compared to cases (Fig. 3, supporting dataset S4). These
bacteria are mucin degraders [39], often found in the human gut
[43], and this work suggests that they may be useful indicators of
gut integrity.
In contrast to controls, the relative absence of Prevotella and
Akkermansia in cases suggests a lack of mucin on the epithelial layer
of intestines of cases, and may be a diagnostic of future or current
gut permeability. In addition, cases have a much larger population
of bacteria such as Bacteroides, Veillonella and Alistipes compared to
controls. These bacteria ferment glucose and lactate to propionate,
acetate, and succinate. Unlike butyrate, these short chain fatty
acids do not induce mucin synthesis [34,35,40,41]. Other factors
may also be increasing mucin synthesis. Addition of a mixture of
amino acids to the diets of dextran sulfate sodium-treated rats also
increases mucin synthesis [44]. The control microbiomes have a
significantly higher abundance of amino acid synthesis genes than
do the case microbiomes.
Figure 6. Model for a bacterial role in gut integrity leading to either a healthy state or autoimmunity for type 1 diabetes. In this
model, the fate of lactate is crucial in determining gut health. Conversion to butyrate results in more mucin synthesis and tighter junctions.
Conversion to other short chain fatty acids (SCHAs) reduces mucin synthesis and tight junctions. Bacterial genera listed are examples of a given
phenotype. Other bacteria may also be involved in these characteristics.
doi:10.1371/journal.pone.0025792.g006
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Although lactic acid producers may be very important in the
maintenance of gut health, the fate of the lactic acid produced by
these bacteria may be equally important. If that fate is butyrate
production, a healthy gut seems more likely. If the microbiome of
the gut encourages the production of other short chain fatty acids,
gut permeability may occur. Other factors also are likely to play a
role in gut inflammation such as the large amount of adhesion
genes found in cases. In addition, Lactobacillus strains can induce
specific changes in the immune system of NOD mice that can
increase or decrease diabetes [45]. Intestinal microbes and the
innate immune system also interact to affect the development of
diabetes in NOD mice [15]. Data presented here and published
elsewhere suggest that microbial-induced butyrate production, and
subsequent mucin synthesis, with a corresponding enhancement of
tight junctions may contribute to the development of autoimmu-
nity for type 1 diabetes in humans.
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